Cabozantinib | sciencenewsnet.in

Breaking News

How one UIC student is proposing to advance science of superconductivity

Ensuring a bright future for diamond electronics and sensors

New Jersey Voters Rank Economy as No. 1 Issue, Followed by Immigration, Character and Reproductive Rights

Scientists’ ‘next-generation’ space materials blast off for tests on ISS

Explaining Science Through Dance

Selenium raised pharmaceutical value of garden sage

“The Southern Advanced Photon Source (SAPS)” by Prof. Hesheng Chen

Structural Safety Monitoring of Buildings with Color Variations

Meal timing may be crucial for night shift workers’ health

Out of Africa: UT Southwestern cardiologist gets to the heart of Zambia’s No. 1 health threat

05 Nov, 2024

MD Anderson Research Highlights for April 24, 2024

April 24, 2024 sarah JonasResearch Results

The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.

Dual-action drug produces positive results in patients with advanced neuroendocrine tumors, trial finds

October 22, 2023 sarah JonasResearch Results

Cabozantinib, which targets tumor cell growth and tumor blood vessel growth, sharply improved progression-free survival over placebo in patients with extra-pancreatic and pancreatic neuroendocrine tumors